Rebecca Heist, MD, Massachusetts General Hospital Cancer Center

Articles by Rebecca Heist, MD, Massachusetts General Hospital Cancer Center

Optimizing Testing Strategies in Non–Small Cell Lung Cancer

ByBenjamin Levy, MD, Johns Hopkins Sidney Kimmel Cancer Center,Lyudmila A. Bazhenova, MD, University of California San Diego,Joshua Bauml, MD, University of Pennsylvania,Rebecca Heist, MD, Massachusetts General Hospital Cancer Center

August 10th 2020

NTRK Fusions in Non–Small Cell Lung Cancer

ByBenjamin Levy, MD, Johns Hopkins Sidney Kimmel Cancer Center,Lyudmila A. Bazhenova, MD, University of California San Diego,Joshua Bauml, MD, University of Pennsylvania,Rebecca Heist, MD, Massachusetts General Hospital Cancer Center

August 10th 2020

MET Exon 14 Mutations in Non–Small Cell Lung Cancer

ByBenjamin Levy, MD, Johns Hopkins Sidney Kimmel Cancer Center,Lyudmila A. Bazhenova, MD, University of California San Diego,Joshua Bauml, MD, University of Pennsylvania,Rebecca Heist, MD, Massachusetts General Hospital Cancer Center

August 10th 2020

RET Fusions in Non–Small Cell Lung Cancer

ByBenjamin Levy, MD, Johns Hopkins Sidney Kimmel Cancer Center,Lyudmila A. Bazhenova, MD, University of California San Diego,Joshua Bauml, MD, University of Pennsylvania,Rebecca Heist, MD, Massachusetts General Hospital Cancer Center

August 10th 2020

ROS1-Rearranged Non–Small Cell Lung Cancer

ByBenjamin Levy, MD, Johns Hopkins Sidney Kimmel Cancer Center,Lyudmila A. Bazhenova, MD, University of California San Diego,Joshua Bauml, MD, University of Pennsylvania,Rebecca Heist, MD, Massachusetts General Hospital Cancer Center

August 10th 2020

Rebiopsy at Progression of ALK-Rearranged NSCLC

ByBenjamin Levy, MD, Johns Hopkins Sidney Kimmel Cancer Center,Lyudmila A. Bazhenova, MD, University of California San Diego,Joshua Bauml, MD, University of Pennsylvania,Rebecca Heist, MD, Massachusetts General Hospital Cancer Center

August 10th 2020

Treating ALK-Rearranged Non–Small Cell Lung Cancer

ByBenjamin Levy, MD, Johns Hopkins Sidney Kimmel Cancer Center,Lyudmila A. Bazhenova, MD, University of California San Diego,Joshua Bauml, MD, University of Pennsylvania,Rebecca Heist, MD, Massachusetts General Hospital Cancer Center

August 10th 2020

Trials in ALK-Rearranged Non–Small Cell Lung Cancer

ByBenjamin Levy, MD, Johns Hopkins Sidney Kimmel Cancer Center,Lyudmila A. Bazhenova, MD, University of California San Diego,Joshua Bauml, MD, University of Pennsylvania,Rebecca Heist, MD, Massachusetts General Hospital Cancer Center

August 10th 2020

KRAS Testing in Non¬–Small Cell Lung Cancer

ByBenjamin Levy, MD, Johns Hopkins Sidney Kimmel Cancer Center,Lyudmila A. Bazhenova, MD, University of California San Diego,Joshua Bauml, MD, University of Pennsylvania,Rebecca Heist, MD, Massachusetts General Hospital Cancer Center

August 10th 2020

Trastuzumab Deruxtecan for HER2+ Non–Small Cell Lung Cancer

ByBenjamin Levy, MD, Johns Hopkins Sidney Kimmel Cancer Center,Lyudmila A. Bazhenova, MD, University of California San Diego,Joshua Bauml, MD, University of Pennsylvania,Rebecca Heist, MD, Massachusetts General Hospital Cancer Center

August 10th 2020

Treating Non–Small Cell Lung Cancer With an EGFR Exon 20 Insertion

ByBenjamin Levy, MD, Johns Hopkins Sidney Kimmel Cancer Center,Lyudmila A. Bazhenova, MD, University of California San Diego,Joshua Bauml, MD, University of Pennsylvania,Rebecca Heist, MD, Massachusetts General Hospital Cancer Center

August 10th 2020

EGFR Exon 20 Mutations in Non–Small Cell Lung Cancer

ByBenjamin Levy, MD, Johns Hopkins Sidney Kimmel Cancer Center,Lyudmila A. Bazhenova, MD, University of California San Diego,Joshua Bauml, MD, University of Pennsylvania,Rebecca Heist, MD, Massachusetts General Hospital Cancer Center

August 10th 2020

Chemotherapy-TKI Combinations in Metastatic EGFR+ Lung Cancer

ByBenjamin Levy, MD, Johns Hopkins Sidney Kimmel Cancer Center,Lyudmila A. Bazhenova, MD, University of California San Diego,Joshua Bauml, MD, University of Pennsylvania,Rebecca Heist, MD, Massachusetts General Hospital Cancer Center

August 10th 2020

TKI Combinations in Metastatic EGFR+ Lung Cancer

ByBenjamin Levy, MD, Johns Hopkins Sidney Kimmel Cancer Center,Lyudmila A. Bazhenova, MD, University of California San Diego,Joshua Bauml, MD, University of Pennsylvania,Rebecca Heist, MD, Massachusetts General Hospital Cancer Center

August 10th 2020

Role of Adjuvant Osimertinib in Early Stage NSCLC

ByBenjamin Levy, MD, Johns Hopkins Sidney Kimmel Cancer Center,Lyudmila A. Bazhenova, MD, University of California San Diego,Joshua Bauml, MD, University of Pennsylvania,Rebecca Heist, MD, Massachusetts General Hospital Cancer Center

August 10th 2020

ADAURA Trial; Early Stage Non–Small Cell Lung Cancer

ByBenjamin Levy, MD, Johns Hopkins Sidney Kimmel Cancer Center,Lyudmila A. Bazhenova, MD, University of California San Diego,Joshua Bauml, MD, University of Pennsylvania,Rebecca Heist, MD, Massachusetts General Hospital Cancer Center

August 10th 2020

Latest Updated Articles

RET Fusions in Non–Small Cell Lung Cancer
August 10th 2020
Trastuzumab Deruxtecan for HER2+ Non–Small Cell Lung Cancer
August 10th 2020
ROS1-Rearranged Non–Small Cell Lung Cancer
August 10th 2020
Role of Adjuvant Osimertinib in Early Stage NSCLC
August 10th 2020
Optimizing Testing Strategies in Non–Small Cell Lung Cancer
August 10th 2020
Treating Non–Small Cell Lung Cancer With an EGFR Exon 20 Insertion
August 10th 2020

Trending on OncLive

FDA Approves Amivantamab and Hyaluronidase for Metastatic HNSCC

BCG Optimization Becomes a Priority as Durvalumab Gains a Role in High-Risk NMIBC

Dr Cai on the Rationale for Evaluating Rocbrutinib Plus R-CHOP in Non-GCB DLBCL and MCL

Dr Skoulidis on Divarasib vs Sotorasib or Adagrasib in KRAS G12C–Mutated NSCLC

Routine Breast Imaging May Offer Little Benefit After Double Mastectomy for Early Breast Cancer